1 - 4 of 4 Results Clear All
Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.
Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCs
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes, next month will receive the Essey Award for his “Commitment to a Cure” from The ALS Association Golden West Chapter. This annual award represents the exceptional determination, spirit and dedication to the fight against amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
ALS Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
CAMBRIDGE, MA and SAN FRANCISCO, CA—The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed the discovery of potential treatments for ALS through the preclinical drug development process.
ALS Finkbeiner Lab
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease)—a fatal disease for which there is no cure.
ALS
